Conclusion Although I-125 plaque brachytherapy has become the treatment of choice for medium-sized choroidal melanoma, there are numerous post-treatment complications of relevance to the ocular oncologist and referring ophthalmologist. Anterior segment pathology occurs in 4–23% of treated patients with ...